Chimera Investment Corporation
NYSE:CIMREIT - Mortgage
+$0.12 today
- Market cap
- $541.62M
- Beta
- 1.76
- P/E (TTM)
- 58.1
- EPS (TTM)
- $0.23
- Dividend yield
- 11.65%
Volume 1.98M
Average 0.70M
CIM Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Chimera Investment CorporationNYSE: CIM
Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026
Accounts receivables turns positive
Q1 FY2026 accounts receivables was $2.33M, compared with -$2.7M a year earlier. Trailing-twelve-month accounts receivables was $11.64M. Over 3 fiscal years it compounded at -5.1% a year.
Context
- Accounts receivables amounted to 0.8% of revenue in FY2025, down 0.9 pp from a year earlier.
- Accounts receivables increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly accounts receivables holds near $2.33M or moves back toward the trailing-twelve-month quarterly average of $2.91M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- 6.61M USD
- Year-over-year change
- +249.3%
- 4-year CAGR
- -13.2%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.61M | +249.3% |
| FY2024 | 2024-12-31 | (4.43M) | +70.8% |
| FY2023 | 2023-12-31 | (15.19M) | -296.2% |
| FY2022 | 2022-12-31 | 7.75M | -33.5% |
| FY2021 | 2021-12-31 | 11.64M | — |
Accounts Receivables vs competitors
How CIM compares with its peers on the latest reported figures
- CIM's LTM Mar 2026 accounts receivables of $11.64M is the 4th largest of the 9 companies compared; the peer median is $0.
- Its year-over-year change of +495.8% is the highest of 5, against a peer median of +31.7%.
- Accounts receivables amounts to 1.8% of revenue for CIM, versus a peer median of 0.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $105.03M | +22.8% | — | 1.3% | |
| LTM Jun 2026 | $22.66M | -14.0% | +22.9% | 2.8% | |
| LTM Mar 2026 | $22.36M | +40.6% | — | 6.6% | |
| LTM Mar 2026 | $11.64M | +495.8% | -5.1% | 1.8% | |
| LTM Mar 2026 | $4.35M | +214.9% | — | 0.6% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding CIM) | $0 | +31.7% | +22.9% | 0.3% | |
Competitors are the stored peer set for CIM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 670.11M | (513.07M) | 126.1M | 176.07M | 266.42M |
| Depreciation & Amortization | 70.58M | 61.49M | 0 | 321K | 7.18M |
| Deferred Income Tax | (70.58M) | 0 | 0 | 0 | 2.27M |
| Stock-Based Compensation | 6.51M | 8.18M | 9.55M | 10.1M | 56.7M |
| Change in Working Capital | (37.57M) | (10.84M) | (30.14M) | (5.84M) | 12.04M |
| Accounts Receivables | 11.64M | 7.75M | (15.19M) | (4.43M) | 6.61M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | (13.2M) | 14.89M | 292K | 13.11M | (5.61M) |
| Other Working Capital | (36.01M) | (33.48M) | (15.24M) | (14.52M) | 11.04M |
| Other Non-Cash Items | (119.87M) | 779.96M | 107.75M | 25.03M | (593.49M) |
| Operating Cash Flow | 519.18M | 325.72M | 213.27M | 205.67M | (248.88M) |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 |
| Acquisitions (Net) | 0 | 0 | 0 | (29.11M) | 0 |
| Purchases of Investments | (227.03M) | (80.93M) | 0 | 0 | 0 |
| Sales of Investments | (45.31M) | 76.47M | 0 | 0 | (23.19M) |
| Other Investing Activities | 2.82B | 514.3M | 551.75M | 207.33M | (1.63B) |
| Investing Cash Flow | 2.55B | 509.84M | 551.75M | 178.22M | (1.66B) |
| Debt Repayment | (2.36B) | (546.31M) | (598.08M) | (298.33M) | 2.32B |
| Common Stock Issued | 0 | 0 | 73.78M | 0 | 0 |
| Common Stock Repurchased | (1.83M) | (48.89M) | (33.1M) | 0 | 0 |
| Dividends Paid | (372.41M) | (361.51M) | (250.53M) | (223.25M) | (208.73M) |
| Other Financing Activities | (220.95M) | 0 | (1K) | 0 | 0 |
| Financing Cash Flow | (2.95B) | (956.7M) | (807.94M) | (521.58M) | 2.11B |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | (5.88M) |
| Net Change in Cash | 116.65M | (121.14M) | (42.92M) | (137.69M) | 194.58M |
| Free Cash Flow | 519.18M | 325.72M | 213.27M | 205.67M | (248.88M) |
Chimera Investment Corporation
NYSE:CIM
Intrinsic Alpha fair value
Locked
Current Price
$6.47
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.